Updated Jul 16, 2026 · Last SEC filing 2026-07-10
UroGen Pharma Ltd. (URGN) has filed 11 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-10. 3 Form 8-K material event filings were reported by URGN in the last 90 days. 4 Form 144 notices of proposed sale were filed for URGN stock. InsiderAlpha tracks every URGN SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SIC classification | Pharmaceutical Preparations (SIC 2834) |
|---|---|
| SEC CIK | 0001668243 |
| Form 4 filings (90d) | 11 |
|---|---|
| Form 8-K filings (90d) | 3 |
| Form 144 notices (90d) | 4 |
| Latest Form 4 filing | 2026-07-10 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Schoenberg Mark | Chief Medical Officer | S — Open-market sale | 10.0K | $40.00 | $400K | SEC | |
| Schoenberg Mark | Chief Medical Officer | S — Open-market sale | 10.0K | $35.01 | $350K | SEC | |
| Schoenberg Mark | Chief Medical Officer | S — Open-market sale | 5.2K | $27.30 | $143K | SEC | |
| Schoenberg Mark | Chief Medical Officer | M — Option exercise | 10.0K | — | — | SEC | |
| Robinson James A. Jr. | Director | M — Option exercise | 2.0K | — | — | SEC | |
| Schoenberg Mark | Chief Medical Officer | S — Open-market sale | 10.0K | $30.00 | $300K | SEC | |
| Schoenberg Mark | Chief Medical Officer | S — Open-market sale | 1.8K | $19.69 | $36K | SEC | |
| Schoenberg Mark | Chief Medical Officer | S — Open-market sale | 1.8K | $19.69 | $36K | SEC | |
| Schoenberg Mark | Chief Medical Officer | S — Open-market sale | 3.7K | $19.69 | $73K | SEC | |
| Smith Jason Drew | General Counsel | S — Open-market sale | 2.7K | $19.69 | $52K | SEC | |
| Smith Jason Drew | General Counsel | S — Open-market sale | 1.6K | $19.69 | $32K | SEC | |
| Smith Jason Drew | General Counsel | S — Open-market sale | 3.2K | $19.69 | $63K | SEC | |
| Schoenberg Mark | Chief Medical Officer | M — Option exercise | 3.3K | — | — | SEC | |
| Schoenberg Mark | Chief Medical Officer | M — Option exercise | 6.7K | — | — | SEC | |
| Smith Jason Drew | General Counsel | M — Option exercise | 5.5K | — | — | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for UroGen Pharma Ltd. (URGN). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Schoenberg Mark | 6 | $1.19M |
| Robinson James A. Jr. | 4 | — |
| WEN LEANA | 2 | — |
| BUTITTA CYNTHIA M | 2 | — |
| Wildman Daniel George | 2 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in URGN insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live URGN dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.